<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01945983</url>
  </required_header>
  <id_info>
    <org_study_id>Si507/2013</org_study_id>
    <nct_id>NCT01945983</nct_id>
  </id_info>
  <brief_title>Early Use of Norepinephrine in Septic Shock Resuscitation</brief_title>
  <acronym>CENSER</acronym>
  <official_title>The Comparison Between Early Norepinephrine Use and Standard Treatment During Severe Sepsis and Septic Shock Resuscitation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Siriraj Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Current septic shock guideline recommends fluid resuscitation as the first treatment.
      Vasopressors, including norepinephrine is recommended to start after achieve adequate fluid
      therapy. This can cause a certain duration of systemic hypotension before vasopressor is
      commenced. Initiation of norepinephrine together with fluid therapy soon after diagnosis of
      septic shock may increase blood pressure quicker than start treatment with intravenous fluid
      alone. The rapid restoration of perfusion pressure may improve septic shock outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will include severe infection patient who had evidence of organ dysfunction and
      hypotension and randomize into 2 groups as following:

        1. Control group. The patient will receive treatment according to septic shock guideline
           2013, which start with intravenous fluid replacement until achieve target central venous
           pressure (CVP) or pulmonary capillary wedge pressure (PCWP) or other fluid responsive
           test goal. If the patient's mean arterial blood pressure still lower than 65 mmHg, then
           norepinephrine or dopamine will initiate to rise blood pressure. The patient will
           receive 5% dextrose water as the placebo of norepinephrine.

        2. Early norepinephrine group. The patient will receive fluid therapy together with low
           dose of norepinephrine (0.05 mcg/kg/min). If after titrate intravenous fluid therapy
           until achieve goal CVP or PCWP or other fluid responsive test, but the mean blood
           pressure still lower than 65 mmHg, then additional titrate dose of norepinephrine will
           be given to the patient according to standard septic shock guideline.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 3, 2013</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Therapeutic goal achievement</measure>
    <time_frame>6 hours</time_frame>
    <description>Therapeutic goal including
Mean arterial blood pressure &gt; or = 65 mmHg
Evidence of adequate tissue perfusion which include continuation of urine output &gt; or = 0.5 ml/kg/hour for 2 hours or decreasing of serum lactate &gt; or = 10 percent in 1 to 2 hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Survive with organ support free days</measure>
    <time_frame>28 days</time_frame>
    <description>The days that patient can survive without vasopressor, ventilator support and renal replacement therapy.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">310</enrollment>
  <condition>Septic Shock</condition>
  <condition>Severe Sepsis</condition>
  <arm_group>
    <arm_group_label>Early norepinephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Norepinephrine 4 mg in 5% dextrose water 250 ml Intravenous infusion rate range from 8 to 15 ml/hour, adjusted according to patient's body weight to achieve norepinephrine 0.05microgram/kg/min Continuous drip for 48 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>5% dextrose water 250 ml Intravenous infusion rate range from 8 to 15 ml/hour. Adjust rate of infusion according to patient's body weight to achieve dosage of norepinephrine comparable to 0.05 microgram/kg/min Continuous drip for 48 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Early norepinephrine</intervention_name>
    <description>Initiation of norepinephrine, a strong vasoconstrictor, at the initiation of septic shock management, together with fluid resuscitation.</description>
    <arm_group_label>Early norepinephrine</arm_group_label>
    <other_name>Early vasopressor therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>5% dextrose water intravenous drip in the same rate of calculated norepinephrine for the patient's body weight</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>5%D/W infusion as the placebo of norepinephrine.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; or = 18 years old

          -  Diagnosed severe sepsis or septic shock according to survival sepsis campaign 2013

          -  Mean arterial pressure &lt; 65 mmHg

        Exclusion Criteria:

          -  Pregnancy

          -  Severe underlying condition that unexpected to survive more than 48 hours

          -  Severe peripheral vascular disease

          -  Patient who required major surgery within 24 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chairat Permpikul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Siriraj Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <results_reference>
    <citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.</citation>
    <PMID>23353941</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2013</study_first_submitted>
  <study_first_submitted_qc>September 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2013</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Septic shock</keyword>
  <keyword>Severe sepsis</keyword>
  <keyword>Norepinephrine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Norepinephrine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

